Publications
The development of Nanosota-1 as anti-SARS-CoV-2 nanobody drug candidates. Elife. 10.7554/eLife.64815
(2021) Structural basis of receptor recognition by SARS-CoV-2. Nature. 10.1038/s41586-020-2179-y
(2020) NECAT
9700 S. Cass Ave.
Bldg. 436E
Argonne, IL 60439
630.252.0689
csalbego@cornell.edu
Copyright © 2024, NECAT
Design by FreeBiezz